GO:0005829; C:cytosol; TAS:Reactome.
GO:0030139; C:endocytic vesicle; IEA:Compara.
GO:0005615; C:extracellular space; IDA:MGI.
GO:0005634; C:nucleus; IEA:Compara.
GO:0034366; C:spherical high-density lipoprotein particle; IEA:Compara.
GO:0034361; C:very-low-density lipoprotein particle; IEA:Compara.
GO:0001540; F:beta-amyloid binding; IEA:Compara.
GO:0015485; F:cholesterol binding; IEA:Compara.
GO:0017127; F:cholesterol transporter activity; IDA:MGI.
GO:0008035; F:high-density lipoprotein particle binding; IDA:MGI.
GO:0055102; F:lipase inhibitor activity; IEA:Compara.
GO:0008289; F:lipid binding; IDA:MGI.
GO:0060228; F:phosphatidylcholine-sterol O-acyltransferase activator activity; IEA:Compara.
GO:0005543; F:phospholipid binding; IEA:Compara.
GO:0005548; F:phospholipid transporter activity; IEA:Compara.
GO:0030325; P:adrenal gland development; IMP:MGI.
GO:0043534; P:blood vessel endothelial cell migration; IMP:MGI.
GO:0006695; P:cholesterol biosynthetic process; IMP:MGI.
GO:0033344; P:cholesterol efflux; IDA:MGI.
GO:0042632; P:cholesterol homeostasis; IEA:Compara.
GO:0070508; P:cholesterol import; IEA:Compara.
GO:0001935; P:endothelial cell proliferation; IMP:MGI.
GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:Compara.
GO:0008211; P:glucocorticoid metabolic process; IMP:MGI.
GO:0034380; P:high-density lipoprotein particle assembly; IEA:Compara.
GO:0019915; P:lipid storage; IMP:MGI.
GO:0042158; P:lipoprotein biosynthetic process; IMP:MGI.
GO:0060354; P:negative regulation of cell adhesion molecule production; IEA:Compara.
GO:0002740; P:negative regulation of cytokine secretion involved in immune response; IEA:Compara.
GO:0034115; P:negative regulation of heterotypic cell-cell adhesion; IEA:Compara.
GO:0051346; P:negative regulation of hydrolase activity; IGI:MGI.
GO:0050728; P:negative regulation of inflammatory response; IEA:Compara.
GO:0050713; P:negative regulation of interleukin-1 beta secretion; IEA:Compara.
GO:0060192; P:negative regulation of lipase activity; IEA:Compara.
GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; IEA:Compara.
GO:0010903; P:negative regulation of very-low-density lipoprotein particle remodeling; IEA:Compara.
GO:0031100; P:organ regeneration; IEA:Compara.
GO:0018206; P:peptidyl-methionine modification; ISS:UniProtKB.
GO:0006656; P:phosphatidylcholine biosynthetic process; IEA:Compara.
GO:0033700; P:phospholipid efflux; IEA:Compara.
GO:0055091; P:phospholipid homeostasis; IEA:Compara.
GO:0006644; P:phospholipid metabolic process; IMP:MGI.
GO:0010873; P:positive regulation of cholesterol esterification; IEA:Compara.
GO:0051345; P:positive regulation of hydrolase activity; IEA:Compara.
GO:0051347; P:positive regulation of transferase activity; IMP:MGI.
GO:0018158; P:protein oxidation; ISS:UniProtKB.
GO:0050821; P:protein stabilization; IEA:Compara.
GO:0032489; P:regulation of Cdc42 protein signal transduction; IEA:Compara.
GO:0030300; P:regulation of intestinal cholesterol absorption; IDA:MGI.
GO:0001932; P:regulation of protein phosphorylation; IDA:MGI.
GO:0042493; P:response to drug; IEA:Compara.
GO:0043627; P:response to estrogen stimulus; IEA:Compara.
GO:0007584; P:response to nutrient; IEA:Compara.
GO:0043691; P:reverse cholesterol transport; IEA:Compara.
GO:0070328; P:triglyceride homeostasis; IEA:Compara.